Region level (promoters) (hyper-/hypomethylated) | Site level (CpG site) (hyper-/hypomethylated) | |
---|---|---|
Histology | ||
NS-EC | 469/38 | 817/183 |
EC-SE | 467/65 | 794/206 |
YST/TE-EC | 501/122 | 953/47 |
YST/TE-SE | 519/31 | 899/101 |
Metastasis-primary | ||
Patient #1 | 209/324 | 500/500 |
Patient #2 | 321/140 | 405/595 |
Patient #3 | 289/210 | 422/578 |
Patient #4 | 337/73 | 655/345 |
Cisplatin resistant-sensitive | 488/8 | 801/199 |